Patents Assigned to LONDONPHARMA LTD.
  • SUBLINGUAL SPRAY FORMULATION COMPRISING DIHYDROARTEMESININ
    Publication number: 20190142737
    Abstract: The invention provides pharmaceutical compositions for the treatment of neoplastic diseases, fluke infestations and Lyme disease, comprising compounds capable of providing dihydroartemesinin and a medium chain triglyceride formulated for transmucosal sublingual, buccal or nasal delivery, especially by a spray. Also provided are delivery devices containing the compositions.
    Type: Application
    Filed: October 18, 2018
    Publication date: May 16, 2019
    Applicant: LondonPharma Ltd.
    Inventor: CALVIN JOHN ROSS
  • SUBLINGUAL SPRAY FORMULATION COMPRISING DIHYDROARTEMESININ
    Publication number: 20170368023
    Abstract: The invention provides pharmaceutical compositions for the treatment of neoplastic diseases, fluke infestations and Lyme disease, comprising compounds capable of providing dihydroartemesinin and a medium chain triglyceride formulated for transmucosal sublingual, buccal or nasal delivery, especially by a spray. Also provided are delivery devices containing the compositions.
    Type: Application
    Filed: September 6, 2017
    Publication date: December 28, 2017
    Applicant: LondonPharma Ltd.
    Inventor: Calvin John Ross
  • Sublingual administration of statins
    Patent number: 9849083
    Abstract: The invention provides a pharmaceutical composition for the transmucosal delivery of a statin, said composition comprising a statin and a carrier in which said statin is soluble or forms a suspension or emulsion. The invention also provides a pharmaceutical composition comprising a statin for use in inhibiting cholesterol synthesis in vivo, where in said use said composition is delivered by the transmucosal route.
    Type: Grant
    Filed: December 14, 2012
    Date of Patent: December 26, 2017
    Assignee: LondonPharma Ltd.
    Inventors: Martin James Sams, Juliet Victoria High, Paul Andrew Jamieson, Clive Booles
  • Sublingual Administration of Statins
    Publication number: 20150328142
    Abstract: The invention provides a pharmaceutical composition for the transmucosal delivery of a statin, said composition comprising a statin and a carrier in which said statin is soluble or forms a suspension or emulsion. The invention also provides a pharmaceutical composition comprising a statin for use in inhibiting cholesterol synthesis in vivo, where in said use said composition is delivered by the transmucosal route.
    Type: Application
    Filed: December 14, 2012
    Publication date: November 19, 2015
    Applicant: LondonPharma Ltd.
    Inventors: Martin James Sams, Juliet Victoria High, Paul Andrew Jamieson, Clive Booles
  • Drug Delivery Technology
    Publication number: 20150005307
    Abstract: The invention provides a pharmaceutical composition for the transmucosal delivery of a PDE5 inhibitor, said composition comprising a PDE5 inhibitor and a carrier in which said PDE5 inhibitor is soluble or forms a suspension or emulsion. The invention also provides a pharmaceutical composition comprising a PDE5 inhibitor for use in inhibiting PDE activity in vivo, where in said use said composition is delivered by the transmucosal route.
    Type: Application
    Filed: December 19, 2012
    Publication date: January 1, 2015
    Applicant: LondonPharma Ltd.
    Inventors: Martin James Sams, Juliet Victoria High, Paul Andrew Jamieson, Clive Booles
  • FORMULATIONS AND DELIVERY
    Publication number: 20130281491
    Abstract: The invention provides pharmaceutical compositions for the sublingual delivery of opioids. The invention also provides delivery devices adapted for sublingual delivery of such compositions.
    Type: Application
    Filed: June 29, 2011
    Publication date: October 24, 2013
    Applicant: LondonPharma Ltd.
    Inventor: Elizabeth Anita Ross
  • Sublingual Spray Formulation Comprising Dihydroartemesinin
    Publication number: 20120157518
    Abstract: The invention provides pharmaceutical compositions for the treatment of neoplastic diseases, fluke infestations and Lyme disease, comprising compounds capable of providing dihydroartemesinin and a medium chain triglyceride formulated for transmucosal sublingual, buccal or nasal delivery, especially by a spray. Also provided are delivery devices containing the compositions.
    Type: Application
    Filed: April 23, 2010
    Publication date: June 21, 2012
    Applicant: LONDONPHARMA LTD.
    Inventors: Calvin John Ross, Elizabeth Anita Ross
  • Sublingual Pharmaceutical Composition Comprising a Neutral Oil
    Publication number: 20120058158
    Abstract: The invention provides pharmaceutical compositions for the sublingual delivery of medicaments comprising a neutral oil and a medicament soluble in said oil, providing that said medicament is not nitroglycerine. The invention also provides delivery devices adapted for sublingual delivery of such compositions.
    Type: Application
    Filed: April 23, 2010
    Publication date: March 8, 2012
    Applicant: LONDONPHARMA LTD.
    Inventor: Clive Booles